Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FAMILIEKIROPRAKTIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.7% 6.4% 5.7% 7.0% 8.0% 10.6% 16.1% 15.9%   Credit score (0-100)   62 38 40 33 30 22 11 12   Credit rating   BBB BBB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,553 1,457 1,422 1,253 919 810 0.0 0.0   EBITDA   447 59.3 50.1 -18.7 -37.7 -143 0.0 0.0   EBIT   358 -1.0 3.1 -54.7 -62.3 -168 0.0 0.0   Pre-tax profit (PTP)   362.2 -3.1 -2.3 -63.3 -73.6 -183.4 0.0 0.0   Net earnings   282.0 -2.7 -1.8 -49.4 -57.6 -146.3 0.0 0.0   Pre-tax profit without non-rec. items   362 -3.1 -2.3 -63.3 -73.6 -183 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   225 165 128 91.7 67.0 42.4 0.0 0.0   Shareholders equity total   379 94.6 92.7 43.3 -14.3 -161 -241 -241   Interest-bearing liabilities   0.0 0.0 58.8 217 329 444 241 241   Balance sheet total (assets)   733 535 426 408 364 349 0.0 0.0   Net Debt   -266 -229 -136 -13.2 171 266 241 241     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,553 1,457 1,422 1,253 919 810 0.0 0.0   Gross profit growth   2.4% -6.2% -2.3% -11.9% -26.7% -11.9% -100.0% 0.0%   Employees   3 3 3 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% -33.3% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   733 535 426 408 364 349 0 0   Balance sheet change%   -10.3% -27.1% -20.4% -4.2% -10.8% -4.1% -100.0% 0.0%   Added value   446.7 59.3 50.1 -18.7 -26.3 -143.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -97 -121 -84 -72 -49 -49 -42 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   23.0% -0.1% 0.2% -4.4% -6.8% -20.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   46.8% 0.6% 0.7% -13.1% -15.9% -37.9% 0.0% 0.0%   ROI %   100.4% 1.5% 2.3% -25.6% -21.1% -43.5% 0.0% 0.0%   ROE %   83.4% -1.1% -2.0% -72.7% -28.3% -41.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.7% 17.7% 21.8% 10.6% -3.8% -31.5% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -59.4% -385.1% -272.0% 71.0% -454.6% -185.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 63.4% 502.2% -2,299.2% -276.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 19.0% 6.3% 4.1% 4.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 0.8 1.0 1.8 5.0 3.9 0.0 0.0   Current Ratio   1.4 0.8 1.0 1.8 5.0 3.9 0.0 0.0   Cash and cash equivalent   265.6 228.5 195.1 230.7 157.6 178.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   127.0 -92.2 -10.2 121.1 198.7 187.7 -120.3 -120.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   149 20 17 -9 -13 -72 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   149 20 17 -9 -19 -72 0 0   EBIT / employee   119 -0 1 -27 -31 -84 0 0   Net earnings / employee   94 -1 -1 -25 -29 -73 0 0